A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies

NCT00207025 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb